Svende Pfundstein Selected Research

AP-102

10/2017

Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Svende Pfundstein Research Topics

Disease

1	Body Weight (Weight, Body) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Vascular Remodeling 01/2020
1	Ischemia 01/2020
1	Acromegaly 10/2017
1	Hyperglycemia 10/2017
1	Diabetes Mellitus 10/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2017

Drug/Important Bio-Agent (IBA)

1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Excipients (Suspending Agents)IBA 01/2022
1	roxadustatIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Cilostazol (Pletal)FDA LinkGeneric 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	AP-102IBA 10/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2017
1	Growth Hormone (Somatotropin)IBA 10/2017
1	pasireotideIBA 10/2017

Therapy/Procedure

1	Ligation 01/2020